Analytes/procedures in 
bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
	
	
	
    
    
    	CAP accredited laboratories that perform testing for the detection of somatic single nucleotide variants, insertions, and deletions in BRAF, EGFR, and KRAS by non-NGS methods are required to enroll in either MTP or the respective single gene programs. This includes laboratories that perform non-NGS-based multiplexed assays, and nonmultiplexed assays (eg, Sanger sequencing). Laboratories that perform NGS-based testing of somatic single nucleotide variants, insertions, and deletions in BRAF, KRAS, EGFR, and/or other genes are required to enroll in NGSST as this proficiency testing program provides challenges with lower VAF as well as challenges in other genes commonly inlcuded in NGS-based panels for the identification of somatic variants in solid tumors.
		
    	
    
    
    Program Information
	
			- Three 2.0‑μg gDNA (50ng/‑μL) specimens for laboratories performing molecular testing on multiple targets
 
		
	 
    
    Shipping Schedule
	
			- 
				Shipment A: February 10
			
 
			- 
				Shipment B: August 18